AI Science Tracker
EN

Department of Anesthesiology, Huzhou Central Hospital, The Affiliated Huzhou Hospital, Zhejiang University School of Medicine, Huzhou, Zhejiang, China

1 discovery from 2022

Discoveries

Identification of two robust subclasses of sepsis with both prognostic and therapeutic values based on machine learning analysis

Source check: Source checked. Not independent scientific confirmation.

Finding: Two transcriptomic subtypes were identified in 1,692 sepsis samples; cluster B had higher observed mortality in the cohort with survival data (60.7% vs 39.3%; p=.044). In a separate dataset, risk scores were associated with response to early supportive therapy (p=.027; AUC .663, 95% CI .516-.789). The two-cluster structure and expression/pathway patterns were assessed in five independent datasets (617 samples). The seven-gene prognostic score used separate training (980) and validation (760) sets. Therapy-response association was assessed in GSE110487 only and is modest/retrospective; it does not establish a treatment effect. The therapy-response association is retrospective and does not establish treatment efficacy or causality.

Technology: K-means clustering of transcriptomic profiles defined the two sepsis subtypes; LASSO and logistic regression produced the seven-gene risk score linked to clinical outcomes.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
K-means clustering of transcriptomic profiles defined the two sepsis subtypes; LASSO and logistic regression produced the seven-gene risk score linked to clinical outcomes.
Test and result
Two transcriptomic subtypes were identified in 1,692 sepsis samples; cluster B had higher observed mortality in the cohort with survival data (60.7% vs 39.3%; p=.044). In a separate dataset, risk scores were associated with response to early supportive therapy (p=.027; AUC .663, 95% CI .516-.789).
Limitation / still unknown
The two-cluster structure and expression/pathway patterns were assessed in five independent datasets (617 samples). The seven-gene prognostic score used separate training (980) and validation (760) sets. Therapy-response association was assessed in GSE110487 only and is modest/retrospective; it does not establish a treatment effect.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.1040286/full

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary source full text Methods and Results; version/date checked against bibliographic record..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.